Charles Morgan Kendrick Jr. - 02 Mar 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Reporting relationship: EVP & President, Commercial
Issuer ticker: ELV
Reported as of: 02 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Mar 2026, 16:58:09 UTC
Prior SEC filing: 05 Mar 2025
Next SEC filing: 09 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathleen S. Kiefer, Attorney in fact

Key filing fact

Charles Morgan Kendrick Jr. filed Form 4 for Elevance Health, Inc. (ELV) on 04 Mar 2026.

Key facts

This page summarizes Charles Morgan Kendrick Jr.'s Form 4 filing for Elevance Health, Inc. (ELV).
5 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Mar 2026, 16:58.

Change

Previous filing in this sequence was filed on 05 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001887908 Primary reporting owner

Kendrick Charles Morgan JR

Relationship: EVP & President, Commercial
Address: 220 VIRGINIA AVE, INDIANAPOLIS
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Signature date: 04 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELV transaction

Common Stock

Tax liability

Transaction value
Shares: -1,211
Change %: -12%
Price: $294.07^*
Shares after: 8,905
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F1

ELV transaction

Common Stock

Award

Transaction value
Shares: +4,017
Change %: +45%
Price: $0.000000^*
Shares after: 12,922
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F2

ELV transaction

Common Stock

Award

Transaction value
Shares: +2,532
Change %: +20%
Price: $0.000000^*
Shares after: 15,454
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F3

ELV transaction

Common Stock

Tax liability

Transaction value
Shares: -467
Change %: -3%
Price: $284.03^*
Shares after: 14,987
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELV transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
Shares: +15,870
Change %
Price: $0.000000^*
Shares after: 15,870
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,870
Exercise price: $294.07
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Footnote F2

Represents restricted share units. Restrictions lapse as follows: 1,339 shares on 3/2/2027, 3/2/2028 and 3/2/2029.

Footnote F3

Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.

Footnote F4

The option represents a right to purchase a total of 15,870 shares, and is exercisable in three annual installments, each installment of 5,290 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.